MX349596B - Metodo para la expresion de polipeptidos usando acidos nucleicos modificados. - Google Patents
Metodo para la expresion de polipeptidos usando acidos nucleicos modificados.Info
- Publication number
- MX349596B MX349596B MX2014011805A MX2014011805A MX349596B MX 349596 B MX349596 B MX 349596B MX 2014011805 A MX2014011805 A MX 2014011805A MX 2014011805 A MX2014011805 A MX 2014011805A MX 349596 B MX349596 B MX 349596B
- Authority
- MX
- Mexico
- Prior art keywords
- group
- polypeptide
- codons
- frequency
- codon
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Abstract
La presente invención se refiere a un método para producir recombinantemente un polipéptido en una célula bacteriana caracterizado porque comprende la etapa de cultivar una célula bacteriana la cual comprende un ácido nucleico que codifica para el polipéptido, y recuperar el polipéptido de la célula bacteriana o del medio de cultivo, en donde cada uno de los residuos aminoácidos del polipéptido es codificado por el menos un codón , por lo que uno o varios de los codones que codifican para el mismo residuo aminoácido se combinan en un grupo y cada uno de los codones en un grupo se define por una frecuencia de uso específica dentro del grupo, la cual es la frecuencia con la cual un codón único de un grupo de codones puede ser encontrado en un ácido nucleico que codifica para un polipéptido en relación a todos los codones de un grupo, por lo que la suma de las frecuencias de uso específicas de todos los codones en un grupo es 100%, en donde la frecuencia de uso general de cada codón en el genoma de la célula es aproximadamente el mismo que su frecuencia de uso específico dentro de su grupo.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12164430 | 2012-04-17 | ||
| PCT/EP2013/057808 WO2013156443A1 (en) | 2012-04-17 | 2013-04-15 | Method for the expression of polypeptides using modified nucleic acids |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2014011805A MX2014011805A (es) | 2014-12-08 |
| MX349596B true MX349596B (es) | 2017-08-04 |
Family
ID=48184161
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2014011805A MX349596B (es) | 2012-04-17 | 2013-04-15 | Metodo para la expresion de polipeptidos usando acidos nucleicos modificados. |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20150246961A1 (es) |
| EP (2) | EP2839011B1 (es) |
| JP (2) | JP6224077B2 (es) |
| KR (1) | KR102064025B1 (es) |
| CN (2) | CN114107352A (es) |
| BR (1) | BR112014025693B1 (es) |
| CA (1) | CA2865676C (es) |
| ES (1) | ES2599386T3 (es) |
| MX (1) | MX349596B (es) |
| RU (1) | RU2014144881A (es) |
| WO (1) | WO2013156443A1 (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114107352A (zh) * | 2012-04-17 | 2022-03-01 | 弗·哈夫曼-拉罗切有限公司 | 使用修饰的核酸表达多肽的方法 |
| CN105916981A (zh) | 2013-07-29 | 2016-08-31 | 丹尼斯科美国公司 | 变体酶 |
| US11345907B2 (en) * | 2018-05-29 | 2022-05-31 | Firmenich Sa | Method for producing albicanol compounds |
| GB201813528D0 (en) | 2018-08-20 | 2018-10-03 | Ucl Business Plc | Factor IX encoding nucleotides |
| MX2021001901A (es) * | 2018-08-20 | 2021-05-27 | Ucl Business Ltd | Nucleotidos de codificacion del factor ix. |
| CA3143803A1 (en) | 2019-06-28 | 2020-12-30 | F. Hoffmann-La Roche Ag | Method for the production of an antibody |
| CN114774391B (zh) * | 2022-03-09 | 2023-03-14 | 华南农业大学 | 一种抗大肠杆菌的噬菌体内溶素及其应用 |
| CN114507682A (zh) * | 2022-03-16 | 2022-05-17 | 华南农业大学 | 编码重组NlpC/P60内肽酶蛋白的基因及其应用 |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5010182A (en) | 1987-07-28 | 1991-04-23 | Chiron Corporation | DNA constructs containing a Kluyveromyces alpha factor leader sequence for directing secretion of heterologous polypeptides |
| AU4005289A (en) | 1988-08-25 | 1990-03-01 | Smithkline Beecham Corporation | Recombinant saccharomyces |
| US5082767A (en) | 1989-02-27 | 1992-01-21 | Hatfield G Wesley | Codon pair utilization |
| US5959177A (en) | 1989-10-27 | 1999-09-28 | The Scripps Research Institute | Transgenic plants expressing assembled secretory antibodies |
| ES2134212T3 (es) | 1991-04-25 | 1999-10-01 | Chugai Pharmaceutical Co Ltd | Anticuerpo humano reconstituido contra el receptor de la interleuquina 6 humano. |
| CA2116774C (en) | 1991-09-19 | 2003-11-11 | Paul J. Carter | Expression in e. coli antibody fragments having at least a cysteine present as a free thiol. use for the production of bifunctional f(ab') 2 antibodies |
| US5795737A (en) | 1994-09-19 | 1998-08-18 | The General Hospital Corporation | High level expression of proteins |
| US5789199A (en) | 1994-11-03 | 1998-08-04 | Genentech, Inc. | Process for bacterial production of polypeptides |
| US5840523A (en) | 1995-03-01 | 1998-11-24 | Genetech, Inc. | Methods and compositions for secretion of heterologous polypeptides |
| US6040498A (en) | 1998-08-11 | 2000-03-21 | North Caroline State University | Genetically engineered duckweed |
| US6291245B1 (en) | 1998-07-15 | 2001-09-18 | Roche Diagnostics Gmbh | Host-vector system |
| EP0972838B1 (en) | 1998-07-15 | 2004-09-15 | Roche Diagnostics GmbH | Escherichia coli host/vector system based on antibiotic-free selection by complementation of an auxotrophy |
| US7125978B1 (en) | 1999-10-04 | 2006-10-24 | Medicago Inc. | Promoter for regulating expression of foreign genes |
| PT1222292E (pt) | 1999-10-04 | 2005-11-30 | Medicago Inc | Metodo para regulacao da transcricao de genes exogenos na presenca de azoto |
| EP1156112B1 (en) | 2000-05-18 | 2006-03-01 | Geneart GmbH | Synthetic gagpol genes and their uses |
| GB0014288D0 (en) * | 2000-06-10 | 2000-08-02 | Smithkline Beecham Biolog | Vaccine |
| DE10037111A1 (de) * | 2000-07-27 | 2002-02-07 | Boehringer Ingelheim Int | Herstellung eines rekombinanten Proteins in einer prokaryontischen Wirtszelle |
| EP1383884A4 (en) * | 2001-03-22 | 2004-12-15 | Dendreon Corp | SERINE PROTEASE CVSP14 CODING NUCLEIC ACID MOLECULES, THE CODED POLYPEPTIDES AND METHODS THEREOF |
| WO2003070957A2 (en) | 2002-02-20 | 2003-08-28 | Novozymes A/S | Plant polypeptide production |
| EP1490494A1 (en) | 2002-04-01 | 2004-12-29 | Walter Reed Army Institute of Research | Method of designing synthetic nucleic acid sequences for optimal protein expression in a host cell |
| US7432342B2 (en) * | 2002-05-03 | 2008-10-07 | Sequenom, Inc. | Kinase anchor protein muteins, peptides thereof and related documents |
| CA2443365C (en) | 2002-11-19 | 2010-01-12 | F. Hoffmann-La Roche Ag | Methods for the recombinant production of antifusogenic peptides |
| GB0308988D0 (en) * | 2003-04-17 | 2003-05-28 | Univ Singapore | Molecule |
| JP4228072B2 (ja) * | 2003-06-04 | 2009-02-25 | 独立行政法人農業・食品産業技術総合研究機構 | アビジンをコードする人工合成遺伝子 |
| US20060024670A1 (en) | 2004-05-18 | 2006-02-02 | Luke Catherine J | Influenza virus vaccine composition and methods of use |
| JP2009538622A (ja) | 2006-05-30 | 2009-11-12 | ダウ グローバル テクノロジーズ インコーポレイティド | コドン最適化法 |
| US7884262B2 (en) | 2006-06-06 | 2011-02-08 | Monsanto Technology Llc | Modified DMO enzyme and methods of its use |
| CN101627053A (zh) * | 2006-06-12 | 2010-01-13 | 西福根有限公司 | 泛细胞表面受体特异的治疗剂 |
| NZ574093A (en) | 2006-06-12 | 2011-03-31 | Symphogen As | Pan-cell surface receptor- specific therapeutics |
| ES2534282T3 (es) | 2006-06-29 | 2015-04-21 | Dsm Ip Assets B.V. | Un método para lograr la expresión polipeptídica mejorada |
| CN114107352A (zh) * | 2012-04-17 | 2022-03-01 | 弗·哈夫曼-拉罗切有限公司 | 使用修饰的核酸表达多肽的方法 |
-
2013
- 2013-04-15 CN CN202111149491.2A patent/CN114107352A/zh active Pending
- 2013-04-15 MX MX2014011805A patent/MX349596B/es active IP Right Grant
- 2013-04-15 WO PCT/EP2013/057808 patent/WO2013156443A1/en not_active Ceased
- 2013-04-15 CA CA2865676A patent/CA2865676C/en active Active
- 2013-04-15 RU RU2014144881A patent/RU2014144881A/ru not_active Application Discontinuation
- 2013-04-15 CN CN201380020266.6A patent/CN104245937B/zh active Active
- 2013-04-15 EP EP13718536.9A patent/EP2839011B1/en active Active
- 2013-04-15 EP EP16188552.0A patent/EP3138917B2/en active Active
- 2013-04-15 ES ES13718536.9T patent/ES2599386T3/es active Active
- 2013-04-15 BR BR112014025693-4A patent/BR112014025693B1/pt active IP Right Grant
- 2013-04-15 KR KR1020147028712A patent/KR102064025B1/ko active Active
- 2013-04-15 JP JP2015506201A patent/JP6224077B2/ja active Active
-
2014
- 2014-10-17 US US14/517,516 patent/US20150246961A1/en not_active Abandoned
-
2017
- 2017-10-04 JP JP2017193965A patent/JP2018038408A/ja active Pending
- 2017-12-06 US US15/833,012 patent/US12577293B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2839011A1 (en) | 2015-02-25 |
| JP2018038408A (ja) | 2018-03-15 |
| KR102064025B1 (ko) | 2020-01-08 |
| KR20140146105A (ko) | 2014-12-24 |
| ES2599386T3 (es) | 2017-02-01 |
| CN114107352A (zh) | 2022-03-01 |
| EP2839011B1 (en) | 2016-09-14 |
| HK1205186A1 (en) | 2015-12-11 |
| CA2865676C (en) | 2020-03-10 |
| BR112014025693B1 (pt) | 2021-12-07 |
| EP3138917A1 (en) | 2017-03-08 |
| JP2015514406A (ja) | 2015-05-21 |
| JP6224077B2 (ja) | 2017-11-01 |
| US20180100006A1 (en) | 2018-04-12 |
| CN104245937A (zh) | 2014-12-24 |
| EP3138917B1 (en) | 2019-08-21 |
| US20150246961A1 (en) | 2015-09-03 |
| CA2865676A1 (en) | 2013-10-24 |
| WO2013156443A1 (en) | 2013-10-24 |
| MX2014011805A (es) | 2014-12-08 |
| US12577293B2 (en) | 2026-03-17 |
| RU2014144881A (ru) | 2016-06-10 |
| CN104245937B (zh) | 2021-09-21 |
| BR112014025693A2 (en) | 2018-08-07 |
| EP3138917B2 (en) | 2024-10-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2014011805A (es) | Metodo para la expresion de polipeptidos usando acidos nucleicos modificados. | |
| AR096270A1 (es) | Composiciones detergentes | |
| MX2020006117A (es) | Integracion dirigida de acidos nucleicos. | |
| MX387336B (es) | Enzimas de clostridium histolyticum y metodos para el uso de los mismos. | |
| MX2023001394A (es) | Genes del factor viii optimizados. | |
| MX2014006396A (es) | Vacunas contra el virus de la influenza y sus usos. | |
| PE20130041A1 (es) | Proteinas de dominio de andamiaje de fibronectina que se unen a interleucina 23 (il-23) | |
| UY33578A (es) | PÉPTIDO O COMPLEJO PEPTÍDICO QUE SE UNE A INTEGRINA a(ALFA) Y MÉTODOS Y USOS QUE IMPLICAN A LOS MISMOS | |
| MX369726B (es) | Polipéptidos con actividad proteasa. | |
| PH12013500995A1 (en) | Methods for increasing yield and fine chemical production in plants | |
| AR102950A1 (es) | Variantes de lipasa y polinucleótidos que las codifican | |
| NZ719881A (en) | Plant cytochrome p450 | |
| FI20115328A0 (fi) | Uusia kutinaaseja, niiden tuottaminen ja käytöt | |
| AR089840A1 (es) | a-AMILASA | |
| PH12013501770A1 (en) | Plants having enhanced yield-related traits and producing methods thereof | |
| AR075932A1 (es) | Proteasa coagulante de leche de tipo mejorado derivada del microorganismo rhizomucor sp | |
| MX2015010078A (es) | Uso de polipeptidos con actividad proteasa en alimentos para animales. | |
| MX349517B (es) | Polipeptidos que tienen actividad de proteasa y polinucleotidos que codifican los mismos. | |
| MX2016011465A (es) | Drimenol-sintasas y metodos para producir drimenol. | |
| MX2017000014A (es) | Metodo para producir acido graso de cadena media con el uso de beta-cetoacil-proteina portadora de acilo (acp) sintasa. | |
| MY183061A (en) | Polypeptides having xylanase activity with a high conversion rate of xylose-containing polysaccharides | |
| PE20211303A1 (es) | Polipeptidos del factor vii de accion corta | |
| MX388061B (es) | Variantes de lipasa y polinucleotidos que las codifican. | |
| MX2014003403A (es) | Polipeptidos que poseen actividad proteasa y polinucleotidos que los codifican. | |
| AR114287A2 (es) | Constructo de un gen quimérico aislado; polipéptido codificado por dicho constructo; y método para conferir a una planta tolerancia a sequía, alta salinidad y congelamiento, excluida la planta obtenida por dicho método |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |